Drug General Information
Drug ID	D05AMX
Former ID	DNC002675
Drug Name	Cysteinesulfonic Acid
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[551393]
Structure		Download 2D MOL 3D MOL
Formula	C3H7NO5S
Canonical SMILES	C(C(C(=O)O)N)S(=O)(=O)O
InChI	1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)
InChIKey	XVOYSCVBGLVSOL-UHFFFAOYSA-N
PubChem Compound ID	25701
PubChem Substance ID	137935, 4865768, 8168664, 14843148, 22389417, 29292597, 49747210, 51073780, 57310047, 76467629, 81051656, 85247149, 87359762, 103768181, 104295257, 119509107, 124409250, 125347436, 125536849, 125537019, 125793420, 126524646, 126546142, 127319592, 127319593, 129747382, 131309571, 134223550, 134990989, 135610185, 136351573, 137007738, 142872473, 162063452, 162293093, 163142782, 164054794, 164829183, 165252212, 179294070, 184535365, 186008906, 223359922, 226428332, 249927023, 252348681
Target and Pathway
Target(s)	M-phase inducer phosphatase 2	Target Info	Inhibitor	[551393]
	mRNA of Protein tyrosine phosphatase-1B	Target Info	Inhibitor	[551393]
	Cathepsin L	Target Info	Inhibitor	[551393]
	Peptide deformylase	Target Info	Inhibitor	[551393]
KEGG Pathway	MAPK signaling pathway
	Cell cycle
	Progesterone-mediated oocyte maturation
	MicroRNAs in cancerhsa04520:Adherens junction
	Insulin signaling pathwayhsa04142:Lysosome
	Phagosome
	Antigen processing and presentation
	Proteoglycans in cancer
	Rheumatoid arthritis
NetPath Pathway	IL2 Signaling Pathway
	TGF_beta_Receptor Signaling Pathway
	Wnt Signaling PathwayNetPath_25:FSH Signaling PathwayNetPath_16:IL4 Signaling Pathway
PANTHER Pathway	Cadherin signaling pathway
Pathway Interaction Database	PLK1 signaling events
	FOXM1 transcription factor network
	p38 signaling mediated by MAPKAP kinases
	Aurora A signalinginsulin_pathway:Insulin Pathway
	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
	Signaling events mediated by PTP1B
	Calcineurin-regulated NFAT-dependent transcription in lymphocytes
	Signaling events mediated by TCPTP
	IGF1 pathway
	EGF receptor (ErbB1) signaling pathway
	Posttranslational regulation of adherens junction stability and dissassembly
	PDGFR-beta signaling pathway
	N-cadherin signaling events
Reactome	Cyclin B2 mediated events
	Cyclin A/B1 associated events during G2/M transition
	Cyclin A:Cdk2-associated events at S phase entryR-HSA-354192:Integrin alphaIIb beta3 signaling
	Regulation of IFNG signaling
	Regulation of IFNA signaling
	Growth hormone receptor signalingR-HSA-1236977:Endosomal/Vacuolar pathway
	Collagen degradation
	Degradation of the extracellular matrix
	Trafficking and processing of endosomal TLR
	Assembly of collagen fibrils and other multimeric structures
	MHC class II antigen presentation
WikiPathways	Senescence and Autophagy in Cancer
	MAPK Signaling Pathway
	Retinoblastoma (RB) in Cancer
	Prostate Cancer
	Integrated Breast Cancer Pathway
	Integrated Cancer pathway
	Mitotic G2-G2/M phases
	Cell CycleWP481:Insulin Signaling
	Growth hormone receptor signaling
	Leptin signaling pathway
	Interferon gamma signaling
	Interferon alpha/beta signaling
	Integrin alphaIIb beta3 signalingWP2572:Primary Focal Segmental Glomerulosclerosis FSGS
References
Ref 551393	How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
Ref 551393	How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.